Current role
Drug Manufacturers - Specialty & Generic · Healthcare
CTO
2022-07-05–present
DR.IGAL LOURIA HAYON
Equibles does not estimate personal net worth.
Get an email with a short summary when Raphael Pharmaceutical Inc. publishes a filing, an earnings call transcript or a press release.
Get RAPH alertsAbout DR.IGAL LOURIA HAYON
DR.IGAL LOURIA HAYON is recorded as CTO at Raphael Pharmaceutical Inc. (RAPH) since July 5, 2022. Raphael Pharmaceutical Inc. reported in an 8-K filed August 11, 2025 that DR.IGAL LOURIA HAYON resigned as director, effective August 1, 2025. Raphael Pharmaceutical Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Raphael Pharmaceutical Inc. includes Ajay Kumar Dhadha (Chairman and Board Member), Uri Tadelis (CFO), Dr. Igal Louria Hayon (Board Member) and 1 other.
“On July 31, 2025, Dr. Igal Louria Hayon, notified the board of directors (the "Board") of Raphael Pharmaceuticals Inc. (the "Company") of his resignation from the Board, effective August 1, 2025.”
Affiliation history
-
Current
2022-07-05–present
-
2022-07-05–2025-08-01
Company network
Leadership on record at Raphael Pharmaceutical Inc.
- Ajay Kumar Dhadha Chairman, Board Member
- Uri Tadelis CFO
- Dr. Igal Louria Hayon Board Member
- Zvi Laufer Laor Board Member